CORE LAB REPORTS Q1 2012 EPS OF $1.13, $1.06 EX-ITEMS;Q1 2012 OPS MARGINS AT 30%, Y-O-Y INCREMENTAL MARGINS AT 49%;DUAL NYSE EURONEXT AMSTERDAM LISTING PLANNED FOR MID-MAY 2012
Record quarter. Guidance after co listing. 150 by May.
LOL, $150 huh, above everyones 12 months price target. Stock fully valued, selling now at 25 times 2013 estimates, it has been a grat run.
$1.06 think was estimate
not getting the same pop as previous reports and the pre markets looking ugly alreadygot some put protection for CLB last week, and thinking about going to cash with some other stufflet the muppets gamble on a squeezeconsider me short until facebook ipo